Applications of 4-Ethoxycarbonyl-3-Fluorophenylboronic Acid in Industrial Manufacturing

4-Ethoxycarbonyl-3-Fluorophenylboronic Acid serves as a specialized intermediate in pharmaceutical synthesis and advanced material research, offering tailored reactivity for coupling reactions in regulated downstream sectors. As a direct manufacturer, we supply this compound with consistent purity, enabling efficient integration into established and emerging industrial applications detailed below.

1. Small Molecule API Synthesis: Antineoplastic Drug Intermediates

Downstream pharmaceutical producers utilize 4-Ethoxycarbonyl-3-Fluorophenylboronic Acid as a key synthon for Suzuki-Miyaura cross-couplings in the assembly of fluorinated biaryl scaffolds within antineoplastic active pharmaceutical ingredients. Formulators calibrate stoichiometry based on the drug candidate’s molecular structure, ensuring high-yield conversion critical to scale-up campaigns. The compound’s purity profile aligns with stringent regulatory thresholds to avoid introduction of unwanted impurities during downstream high-pressure liquid chromatographic purification and solid-phase synthesis workflows.

Industry compliance standards

• ICH Q7A GMP for Active Pharmaceutical Ingredients
• 21 CFR Parts 210/211 (US FDA Finished Pharmaceuticals)
• EU GMP EudraLex Vol. 4, Part II
• Ph. Eur. Monographs for fluorinated APIs (where applicable)

Typical usage ratio

• 0.9–1.2 molar equivalents, adjusted for yield optimization and minimal boronate residuals in final product

Downstream process integration

• Introduced during post-core build Suzuki cross-coupling as the boronic acid partner, followed by workup, phase separation, and final purification using preparative HPLC or crystallization

Final product types

• Oral and injectable cancer therapeutics (e.g., fluorinated kinase inhibitors, anti-androgen compounds)

2. Advanced Agrochemical Synthesis: Herbicide and Fungicide Intermediates

Leading agrochemical manufacturers rely on this boronic acid derivative for selective C–C bond formation when producing next-generation fluorinated phenyl scaffolds. Its incorporation addresses synthetic bottlenecks associated with introducing both ethoxycarbonyl and fluorine groups on aromatic rings, producing higher-quality intermediates suited for robust environmental safety reviews. Application chemists determine input ratios based on downstream crude yield and process mass intensity, ensuring compliance from pilot to full-volume batches.

Industry compliance standards

• FAO/WHO Specification for Agricultural Pesticides
• ISO 9001:2015 (Quality Management Systems – Agrochemical Production)
• REACH Registration (Annex I, where applicable for intermediates)
• OECD GLP for Environmental Testing

Typical usage ratio

• 1.0–1.3 equivalents by mole in cross-coupling step, tuned for desired regioselectivity and conversion efficiency

Downstream process integration

• Deployed in palladium-catalyzed couplings to append phenylboronic motifs onto protected intermediates, followed by hydrolysis, extraction, and formulation into bulk actives

Final product types

• Fluorinated pre-emergent herbicides
• Broad-spectrum microbicide actives

3. Specialty Chemical Manufacturing: OLED and Electronic Film Materials

Producers of specialty electronic films and display materials use this compound as a precision building block for synthesizing fluorinated aryl compounds in light-emitting diode (OLED) applications. Its unique substitution pattern supports electron-withdrawing group placement required for efficient charge transport, providing a reproducible route for coupling with halogenated aromatic cores. Chemists closely monitor the input ratio to minimize boron-containing residues that could impact final film conductivity.

Industry compliance standards

• ISO 14001 Environmental Management (Relevant Electronic Chemicals)
• RoHS Directive (2011/65/EU) for electronic components
• IPC-4101B for base materials in printed electronics
• REACH Regulation (as applicable to specialty monomers)

Typical usage ratio

• 1.0–1.1 equivalents per mole of halogenated substrate; chemists fine-tune based on electronic characteristics targeted in final OLED layer

Downstream process integration

• Applied in batch couplings under inert atmosphere, preceding purification by column chromatography and vacuum drying for further oligomerization or device assembly

Final product types

• High-efficiency blue and green OLED emitter layers
• Fluorinated polyaryl films for thin-film transistor (TFT) backplanes

4. Fluorinated Building Blocks for Research Chemicals and Custom Libraries

Chemical R&D organizations deploy this phenylboronic acid as a source molecule for generating small-molecule libraries, where precise fluorine and ester group placement is required to manipulate biological or physical properties. Usage levels depend on library size and structure diversity; researchers generally maintain slight excesses to drive completeness in automated or parallel synthesis environments. Quality and traceability ensure scientists can assign structure-activity relationships with minimal background noise from synthetic byproducts.

Industry compliance standards

• ISO 9001:2015 R&D and Laboratory Quality Management
• OECD Principles of Good Laboratory Practice (GLP)
• Institutional chemical registration (GHS-adapted safety labeling)
• Material registration with relevant authorities for export control

Typical usage ratio

• 0.95–1.5 equivalents by substrate, depending on combinatorial synthesis target and platform throughput

Downstream process integration

• Dispensed via automated liquid handlers in parallel synthesis arrays, with subsequent purification by high-throughput chromatography or crystallization prior to analytical QC and storage

Final product types

• Custom fluorinated aromatic compound libraries for pharma and crop protection screening
• Lead molecule sets for contract research organizations

5. Synthesis of PET Imaging Probes for Biomedical Applications

Manufacturers engaged in the development of fluorinated tracers for positron emission tomography (PET) choose this boronic acid for regioselective construction of labeled aromatic units, supporting downstream radiofluorination. Strict process controls around usage ratio and purity help prevent isotopic dilution during labeling, while formulated protocols meet obligations for clinical tracer batch reproducibility and safety. Input ratio varies depending on the specific aromatic prosthetic group and efficiency of subsequent isotope exchange steps.

Industry compliance standards

• EU GMP Guidelines for Investigational Radiopharmaceuticals
• USP Chapter <825> Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging
• ISO 13485:2016 Medical Devices—Quality Management Systems
• National and international nuclear regulatory authority licensing

Typical usage ratio

• 1.0–1.2 equivalents, defined per substrate based on desired molar activity and production batch size for clinical or preclinical tracer preparation

Downstream process integration

• Inserted during the formation of cold precursor via Suzuki coupling, followed by radiofluorination, preparative HPLC purification, sterile filtration, and onsite formulation for injection

Final product types

• 18F-labeled PET imaging agents for oncology, neurology, and cardiovascular diagnostics